CALI: CalciMedica Corp Analyst Consensus Forecast

Corporate company logo of CalciMedica Corp (CALI)

The price action for CalciMedica, Inc. (CALI) reflects a trend driven by the outsourcing of manufacturing processes to third-party contractors, which minimizes capital expenditures. The company's environmental profile is based on safe waste recycling and office digitalization, with the indicator standing at 0.00. Economic stability is supported by the optimization of supply chains for heat-sensitive materials, ensuring high returns across all development projects.

CalciMedica Corp - CALI Analyst Consensus Forecast (period 10/11/2024 - 10/17/2026)

Analytical breakdowns for CalciMedica, Inc. (CALI)

- market price and analyst price targets:
General company analysis:CALI CalciMedica Inc
Flagship merchandise of CalciMedica

Analyzing the fundamental risks of CalciMedica, Inc. (CALI) requires comparing the market price with the average target of analyst coverage, which measures the expected value of the stock over a one-year horizon. For the biotechnology sector, where ESG filtration and water consumption standards impact the operating expenses of CalciMedica, Inc. (CALI), this indicator smooths volatility, allowing investors to assess the asset's actual undervaluation potential or the risk of inflated expectations.

Competitors of CalciMedica, Inc.

Consensus Target argenx.com ARGX|Analyst Consensus Forecast BNTX (BioNTech)|Analyst Consensus Forecast Abivax SA ABVX|ADMA - Price Target Chart|PTGX: Price Target Chart|IMVT: Analyst Consensus Forecast|KNSA - Analyst Median Target|Price Target Chart Grifols|Adaptive Biotech - Forecast Levels Chart|Analyst Consensus Forecast CLDX|AUPH (Aurinia Corp) - Fair Value Consensus|Analyst Consensus Forecast BCRX (BioCryst)|Analyst Consensus Forecast veratx.com VERA|DNTH - Price Target Chart|Fair Value Consensus PHVS (Pharvaris NV)|AbCellera (ABCL) - Price Target Chart|Consensus Target Tourmaline|PGEN (Precigen, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast pharming.com|Consensus Target NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Fair Value Consensus|Analyst Consensus Forecast ZBIO (Zenas Biopharma, Inc.)|Analyst Median Target Immunome Bio (IMNM)|GOSS - Price Target Chart|kalvista.com (KALV) - Consensus Target|Septerna (SEPN) - Price Target Chart|Consensus Target Pieris Pharma|Consensus Target SVRA|Analyst Consensus Forecast Rigel Corp|Price Target Chart AnaptysBio, Inc. (ANAB)|astriatx.com - Broker Consensus Forecast|Analyst Consensus Forecast ENGN (enGene)|rapt.com (RAPT) - Average Forecast Price|Aerovate - Analyst Consensus Forecast|Aclaris Therapeutics, Inc (ACRS) - Consensus Target|KYTX: Analyst Consensus Forecast|tizianalifesciences.com (TLSA) - Analyst Consensus Forecast|Price Target Chart Cabaletta Bio|Price Target Chart VTYX|Analyst Consensus Forecast THTX|Consensus Target Avalo Therapeutics Inc AVTX|Analyst Consensus Forecast ELDN (Eledon Pharmaceuticals)|Analyst Median Target agenusbio.com (AGEN)|CLYM - Price Target Chart|zurabio.com (ZURA) - Consensus Target|ATYR: Analyst Consensus Forecast|Average Forecast Price Adagene Inc. (ADAG)|IMA (ImageneBio) - Analyst Consensus Forecast|Broker Consensus Forecast STTK (Shattuck Therapeutics)|Analyst Consensus Forecast EQ|Analyst Median Target connectbiopharm.com|Analyst Consensus Forecast IMUX (Immunic)|ATRA - Consensus Target|InflaRx GmbH - Analyst Consensus Forecast|XFOR - Analyst Consensus Forecast|ACET (adicetbio.com) - Consensus Target|Celularity - Fair Value Consensus|INMB (INmune Bio Corp) - Analyst Consensus Forecast|Barinthus Biotherapeutics Corp (BRNS) - Analyst Median Target|Price Target Chart Kezar Life Sciences (KZR)|sabbiotherapeutics.com - Broker Consensus Forecast|Analyst Consensus Forecast AKTX (Akari Therapeutics Plc)|ENLV - Consensus Target|QTTB: Consensus Target|Analyst Median Target GeoVax Corp GOVX|EDSA: Analyst Consensus Forecast|Consensus Target ibioinc.com|CARM (Carisma Therapeutics Inc) - Analyst Consensus Forecast|Analyst Consensus Forecast XTL Biopharmaceuticals Ltd|Price Target Chart Bolt Biotherapeutics (BOLT)|Price Target Chart HCWB (hcwbiologics.com)|Analyst Consensus Forecast APVO (Aptevo Therapeutics Inc.)|Analyst Median Target aimimmuno.com (AIM)|ADTX - Price Target Chart|Forecast Levels Chart GRI|XRTX: Analyst Consensus Forecast|Vyome Therapeutics - Fair Value Consensus|REVB (Revelation Biosciences) - Analyst Consensus Forecast|Analyst Consensus Forecast indaptusrx.com|Price Target Chart Scinai Immunotherapeutics Ltd. (SCNI)|AFMD (affimed.com) - Fair Value Consensus|Price Target Chart Allakos ALLK|HOOK - Consensus Target|IGM Bio - Analyst Consensus Forecast|ITOS - Analyst Consensus Forecast|OCEA (Ocean Biomedical) - Consensus Target|TC BioPharm (Holdings) Plc - Fair Value Consensus|THRD (Third Harmonic Bio, Inc) - Analyst Consensus Forecast